The ctDNA profiles of HCC in this cohort demonstrated the expected distribution of HCC genomic alterations,6 with frequent alterations in TP53, CTNNB1, and TERT (Fig. 1A). The gene discussed is TP53; the disease is hepatocellular carcinoma.